Patent US4495168A successfully refreshed from Google Patents.
Patent US4153417A successfully refreshed from Google Patents.
US4153417A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of indicating rheumatoid factors
Assignee: HALLGREN HENNING ROGER
•
Filing: 1977-07-25
•
Granted: 1979-05-08
•
Expires: 1997-07-25
Abstract
Abstract A method of indicating rheumatoid factors belonging to at least one of the immunoglobulin classes IgM, IgG and IgA in an aqueous sample is disclosed. According to this method any complement factor C1q present in the sample is pacified in a manner known per se, whereafter the sample is reacted with soluble, aggregated immunoglobulin labelled with one or more analytically indictable atoms or groups to form aggregates between rheumatoid factors and the aggregated, labelled immunoglobulin, said aggregate being precipitated out, whereafter the precipitate is separated and the analytically indicatable atoms or groups are indicated in the precipitation phase and/or in the solution.
Inventors
- 👤 Henning R. Hallgren
- 👤 Leif E. Wide
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 23:57
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/564; Y; Y10; Y10S; Y10S435/00; Y10S435/962; Y10S436/00; Y10S436/80; Y10S436/804; Y10S436/819; Y10S436/821; Y10S436/826
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
92 words
A method of indicating rheumatoid factors belonging to at least one of the immunoglobulin classes IgM, IgG and IgA in an aqueous sample, which method comprises (a) pacifying any complement factor C1q present in the sample, (b) thereafter reacting the sample with soluble, aggregated immunoglobulin labelled with one or more analytically indicatable atoms or groups to form aggregates between rheumatoid factors and the aggregated, labelled immunoglobulin, said aggregates being precipitated out, (c) separating the precipitate, and (d) thereafter measuring indicatable atoms or groups in the precipitated phase formed and/or in the solution.
Claim 2
Independent Claim
92 words
A method of indicating rheumatoid factors belonging to at least one of the immunoglobulin classes IgM, IgG and IgA in an aqueous sample, which method comprises (a) pacifying any complement factor C1q present in the sample, (b) thereafter reacting the sample with soluble, aggregated immunoglobulin labelled with one or more analytically indicatable atoms or groups to form aggregates between rheumatoid factors and the aggregated, labelled immunoglobulin, said aggregates being precipitated out, (c) separating the precipitate, and (d) thereafter measuring indicatable atoms or groups in the precipitated phase formed and/or in the solution.
Claim 3
Dependent Claim
16 words
A method according to claim 1 wherein the labelled aggregated immunoglobulin belongs to the IgG class.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-05-07 | 1982-11-06 | 1983-05-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-05-07 | 1986-11-06 | 1987-05-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-05-07 | 1990-11-06 | 1991-05-08 | $7700.00 | Window Closed / Lapsed |